News

Filter by Category

Filter by Program

Filter by Publish Date

August 22, 2024

C-Path’s TRxA Announces $250,000 Grant for Drug Development Project in Prostate Cancer

C-Path proudly announced today a $250,000 grant award to Peter Wipf, Ph.D...

August 20, 2024

C-Path has received its first data transfer of natural history data on single large-scale mitochondrial DNA...

August 20, 2024

C-Path today announced a strategic data sharing partnership with Vivli, the nonprofit...

August 13, 2024

C-Path) Translational Therapeutics Accelerator (TRxA) announced today that Kenneth Keiler...

August 12, 2024

C-Path is thrilled to welcome CuraSen Therapeutics as the newest member of its Critical Path for Parkinson’s Consortium.

August 8, 2024

C-Path)'sTranslational Therapeutics Accelerator (TRxA) announced today a new research grant awarded...

August 6, 2024

C-Path's Critical Path for Alpha-1 Antitrypsin Deficiency (CPA-1) consortium today announced the addition of several...

July 31, 2024

I am a Clinical Outcome Assessment (COA) Scientist in the COA Program at C-Path.

July 26, 2024

C-Path is proud to announce the publication of a new study in the journal Alzheimer’s & Dementia...

June 20, 2024

C-Path, a leader in forming collaborations that accelerate drug development, and Centogene N.V. (Nasdaq: CNTG)...